This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
The HeartRhythm Society (HRS) is preparing for HRX 2024, the third annual event of its kind, which will be held from September 5-7, 2024, in Atlanta, GA, gathering cardiovascular health innovators together to explore discoveries and advance partnerships between medicine and technology. Avari Silva On Saturday, Sept.
milla1cf Thu, 05/30/2024 - 10:31 May 30, 2024 — Stereotaxis , a pioneer in surgical robotics for minimally invasive endovascular intervention, announced the successful treatment of the first heartrhythmpatients by Penn Presbyterian Medical Center (PPMC) utilizing the advanced Genesis Robotic Magnetic Navigation System.
The electrical conduction system [1] In schematic depiction of a normal sinus rhythm the P-wave represents atrial depolarization, the QRS complex symbolizes ventricular depolarization, and the T-wave indicates ventricular repolarization. Sinus tachycardia – sinus rhythm above 100 bpm is a sinus tachycardia.
The solution integrates remote patient monitoring (RPM) technologies and advanced arrhythmia detection algorithms, streamlining deployment and enhancing patientcare to meet the increasing demand for efficient ambulatory ECG monitoring solutions.
milla1cf Fri, 05/17/2024 - 18:54 May 17, 2024 — Royal Philips , a global leader in health technology, is presenting new retrospective study results demonstrating the clinical and economic benefits of Philips’ AI-powered cardiac care solutions at the HeartRhythm Annual Meeting in Boston (May 16-19).
a global leader in cardiac arrhythmia treatment and part of Johnson & Johnson MedTechi , revealed findings from a company-funded study of real-world data. AFib is the most common type of cardiac arrhythmia and affects more than 6 million people in the United States and nearly 38 million people worldwide.2,3
At this year’s HeartRhythm Society (HRS) conference in Boston in May, innovation, again, was the focus. PFA is designed to address AFib, the most common arrhythmia in the US, with a growing patient population. Pulsed field ablation (PFA) is all the rage in electrophysiology.
David Newton , Clinical Cardiac Electrophysiologist at Memorial Health University Physicians HeartCare and Dr. Andrea Natale , Executive Medical Director at T exas Cardiac Arrhythmia Institute, St. David’s Medical Center. Approximately 1 in 4 adults over the age of 40 are at risk for developing AFib.
In response, an increasing number of clinics have chosen to rely on cardiac remote patient monitoring ( RPM ) software. This software is transforming preventative healthcare, as it optimizes clinic management and improves patientcare. RPM solutions are improving healthcare outcomes and helping patients lead healthier lives.
These remote monitoring capabilities quickly advanced and gave physicians access to patient data for more immediate and accurate diagnosis and treatment of arrhythmias. With the increasing adoption remote cardiac monitoring, the HeartRhythm Society released a consensus statement in 2015.
Volta Medical has announced it has entered into a Joint Development Agreement with GE Healthcare to enhance arrhythmia procedures with artificial intelligence (AI)-driven electrophysiology technologies. Our mission to combat complex heartrhythm diseases relies on optimizing interoperability.
The Smidt Heart Institute recently received CAROL Act funding to study the connection between ventricular arrhythmias—abnormal heartbeats that start in the heart’s two lower chambers—and an elevated risk of sudden cardiac death in patients with mitral valve disease.
Significance: Landiolol offers a new, highly selective beta-1 blocker for managing abnormally fast heartrhythms, addressing an important need in cardiac health management. Heart rate reduction within 10 minutes : Landiolol: 40%-90%. Heart rate decrease criteria: >20% decrease, HR <100 bpm, or arrhythmia cessation.
We organize all of the trending information in your field so you don't have to. Join thousands of users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content